ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2589 • 2012 ACR/ARHP Annual Meeting

    From Novice to Expert: Competency Milestones for Musculoskeletal Ultrasound

    Karina D. Torralba1, Jay B. Higgs2, Amy C. Cannella3 and Gurjit S. Kaeley4, 1Rheumatology, Keck School of Medicine, University of Southern California, Los Angeles, CA, 2Rheumatology, San Antonio Military Medical Center, Fort Sam Houston, TX, 3Divison of Rheumatology, University of Nebraska Med Ctr, Omaha, NE, 4University of Florida, Ponte Vedra Beach, FL

    Background/Purpose: The Accreditation Council for Graduate Medical Education and the American Board of Internal Medicine have initiated the development of milestones for internal medicine (IM)…
  • Abstract Number: 2590 • 2012 ACR/ARHP Annual Meeting

    Consolidating  Knowledge, Comprehension, Application and Analysis in Rheumatology Education by Use of an in-House Electronic Module (Web-based Rheumatology Case Scenarios)

    David A. Kandiah, Diana Jonas-Dwyer and Astrid Davine, Faculty of Medicine, Dentistry and Health Sciences (M515), University of Western Australia, Crawley, Australia

    Background/Purpose: The teaching and learning resource “Rheumatology Case Scenarios” was created as a web-based module. This electronic module was produced to maximise the interactive learning opportunities…
  • Abstract Number: 2591 • 2012 ACR/ARHP Annual Meeting

    Assessment of Examination Skills of 4th Year Medical Students Using a Novel Objective Structured Clinical Examination

    Seetha U. Monrad1, Lisa DiPonio2, Cliff Craig3, John Zeller3 and R. Brent Stansfield4, 1Div of Rheumatology, Univ of Michigan Med Ctr, Ann Arbor, MI, 2Physical Medicine & Rehabilitation, Univ of Michigan Med Ctr, Ann Arbor, MI, 3Orthopaedic Surgery, Univ of Michigan Med Ctr, Ann Arbor, MI, 4Medical Education, Univ of Michigan Med Ctr, Ann Arbor, MI

    Background/Purpose: University of Michigan (UM) medical students participate in integrated musculoskeletal sequences during their preclinical years, but subsequently there are few opportunities for assessment of…
  • Abstract Number: 2592 • 2012 ACR/ARHP Annual Meeting

    Musculoskeletal Ultrasound Objective Structured Clinical Examination : An Assessment of the Test

    Eugene Y. Kissin1, Peter C. Grayson2, Amy C. Cannella3, Amy M. Evangelisto4, Janak R. Goyal5, Rany Al Haj6, Jay B. Higgs7, Daniel G. Malone8, Midori Jane Nishio9, Darren Tabechian10 and Gurjit S. Kaeley11, 1Rheumatology, Boston University, Boston, MA, 2Section of Rheumatology & the Clinical Epidemiology Unit, Boston University School of Medicine, Vasculitis Center, Boston, MA, 3Divison of Rheumatology, University of Nebraska Med Ctr, Omaha, NE, 4Arthritis, Rheumatic and Back Disease Associates, Voorhees, NJ, 5Medicine, Raritan Bay Medical Center, Perth Amboy, NJ, 6Rheumatology, Shore Arthritis & Rheumatism Associates, Ocean, NJ, 7Rheumatology, San Antonio Military Medical Center, Fort Sam Houston, TX, 8Family & Sports Orthopaedic Center, Beaver Dam, WI, 9Diablo Clinical Research, Walnut Creek, CA, 10Allergy/Immun/Rheumatology, Univ of Rochester Schl of Med, Rochester, NY, 11University of Florida, Ponte Vedra Beach, FL

    Background/Purpose: There is debate about whether an objective structured clinical examination (OSCE) should be part of musculoskeletal ultrasound (MSUS) competency testing in MSUS, and the…
  • Abstract Number: 2593 • 2012 ACR/ARHP Annual Meeting

    Predictive Markers of Therapeutical Outcome and Their Role in the Ethiopathology of Juvenile Idiopathic Arthritis

    Maura Rossetti1, Roberto Spreafico1, Hong Zhang1, Maryam Moshref1, Nora G. Singer2, D. J. Lovell3, Carol A. Wallace4 and Salvatore Albani5, 1Translational Immunology, Sanford-Burnham Medical Research Institute, La Jolla, CA, 2Rheumatology, MetroHealth Medical Center, Cleveland, OH, 3Cincinnati Children's Hospital, Cincinnati, OH, 4Pediatrics, Seattle Childrens Hospital, Seattle, WA, 5Translational Research Program, Infectious and Inflammatory Diseases, Sanford-Burnham Medical Research Institute, La Jolla, CA

    Background/Purpose: Currently, juvenile idiopathic arthritis (JIA) is treated with methotrexate (MTX) as a first-line agent. If children fail to respond, a biologic (e.g. anti-TNF) is…
  • Abstract Number: 2594 • 2012 ACR/ARHP Annual Meeting

    Epigenetic Signature of the Response to Anti-TNF in Juvenile Idiopathic Arthritis

    Roberto Spreafico1, Maura Rossetti1, Hong Zhang1, Maryam Moshref1, Carol Wallace2, D. J. Lovell3 and Salvatore Albani4, 1Translational Immunology, Sanford-Burnham Medical Research Institute, La Jolla, CA, 2Div Rheumatology-Pediatrics, Childrens Hosp & Regional Med, Seattle, WA, 3Cincinnati Children's Hospital, Cincinnati, OH, 4Translational Research Program, Infectious and Inflammatory Diseases, Sanford-Burnham Medical Research Institute, La Jolla, CA

    Background/Purpose: The identification of prognostic markers of responsiveness to the therapy  in JIA would not only radically improve clinical management, but also shed light on…
  • Abstract Number: 2595 • 2012 ACR/ARHP Annual Meeting

    S100A12 At Baseline May Be Useful for Predicting Inactive Disease within 12 Months in Polyarticular Juvenile Idiopathic Arthritis

    Gali Malul1, Joy M. Whitbred1, MaryAnn O'Riordan2, Sarah Ringold3, Susan D. Thompson4, Carol Wallace5, Salvatore Albani6 and Nora G. Singer7, 1Rheumatology, MetroHealth Medical Center, Cleveland, OH, 2Pediatrics, Case Medical Center, Cleveland, OH, 3Pediatrics, Seattle Children's Hospital/Univ of Washington, Seattle, WA, 4Department of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Div Rheumatology-Pediatrics, Childrens Hosp & Regional Med, Seattle, WA, 6Translational Research Program, Infectious and Inflammatory Diseases, Sanford-Burnham Medical Research Institute, La Jolla, CA, 7Medicine, Division of Rheumatology, MetroHealth Medical Center, Cleveland, OH

    Background/Purpose: Achieving clinically inactive disease (ID) is a therapeutic goal in JIA. ID is defined as: no active arthritis; no fever, rash, serositis, splenomegaly or…
  • Abstract Number: 2596 • 2012 ACR/ARHP Annual Meeting

    Rituximab Treatment for Antineutrophil Cytoplasmic Antibody – Associated Vasculitis in Children

    Katharine F. Moore1, Leonard L. Dragone2, Jennifer B. Soep3 and J. Roger Hollister4, 1Pediatric Rheumatology, Seattle Children's Hospital / University of Washington, Seattle, WA, 2Dept of Pediatrics, National Jewish Health, Denver, CO, 3Pediatric Rheumatology, Children's Hospital Colorado, Aurora, CO, 4Dept of Pediatrics, Children's Hospital Colorado, Aurora, CO

    Background/Purpose: The purpose of this study was to report the experience of a tertiary-care children’s hospital using rituximab in the treatment of pediatric antineutrophil cytoplasmic…
  • Abstract Number: 2597 • 2012 ACR/ARHP Annual Meeting

    Degree of Initial Intracellular Folate Depletion May Predict Methotrexate Response in Juvenile Idiopathic Arthritis

    Leon van Haandel1, Ryan S. Funk1, Maria F. Ibarra2, Mark F. Hoeltzel3, Andrew Lasky4, Daisy Dai5, Rodger Gaedigk1, J. Steven Leeder6 and Mara L Becker5, 1Clinical Pharmacology and Medical Toxicology, Children's Mercy Hospital, Kansas City, MO, 2Pediatric Rheumatolgy, Children's Mercy Hospital, Kansas City, MO, 3Rheumatology Section, Children's Mercy Hospital, Kansas City, MO, 4Pediatrics Rheumatology, Children's Mercy Hospital, Kansas City, MO, 5Clinical Pharmacology and Rheumatology, Children's Mercy Hospital, Kansas City, MO, 6Individualized medicine, Children's Mercy Hospital, Kansas City, MO

    Background/Purpose: Despite widespread use, there are no predictors of methotrexate (MTX) response or toxicity.  The objective of this study is to test the hypothesis that…
  • Abstract Number: 2598 • 2012 ACR/ARHP Annual Meeting

    Anti-Drug Antibodies Are Associated with Diminished Drug Levels and Treatment Failure

    Miha Kosmac1, Natasa Toplak2, Gabriele Simonini3, Ilaria Pagnini4, Rolando Cimaz5, Vladka Curin Serbec1 and Tadej Avcin5, 1Research and Development Unit, Blood Transfusion Centre of Slovenia, Ljubljana, Slovenia, 2Department of Allergology, Rheumatology and Clinical Immunology, University Children's Hospital Ljubljana Slovenia, Ljubljana, Slovenia, 3Rheumatology Unit-Department of Paediatrics, A. Meyer Children's Hospital, Florence, Italy, 4Rheumatoloy Unit, Anna Meyer Children's Hospital, Department of Pediatrics, University of Florence, Florence, Italy, 5Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy

    Background/Purpose: Due to their proteinaceus character biologics can often induce an unwanted immune response that results in the formation of anti-drug antibodies in patients receiving…
  • Abstract Number: 2599 • 2012 ACR/ARHP Annual Meeting

    Quality of Care for Medicare Recipients with Rheumatoid Arthritis: Vulnerable Populations More Likely to Receive Therapy with Glucocorticoids Alone

    Chris Tonner1, Gabriela Schmajuk2, Amal N. Trivedi3, Grace Lin4 and Jinoos Yazdany5, 1Medicine, UCSF, San Francisco, CA, 2Rheumatology, UCSF / San Francisco VA Medical Center, San Francisco, CA, 3Department of Community Health, Brown University, Providence, RI, 4General Internal Medicine, University of California San Francisco, San Francisco, CA, 5Medicine, University of California, San Francisco, San Francisco, CA

    Background/Purpose:   Use of disease-modifying anti-rheumatic drugs (DMARDs) is a nationally endorsed quality measure, yet recent studies suggest that only 60% of Medicare recipients with…
  • Abstract Number: 2600 • 2012 ACR/ARHP Annual Meeting

    Assessment of Quality of Care for Incident Lupus Nephritis in the U.S. Medicaid Population

    Jinoos Yazdany1, Candace H. Feldman2, Jun Liu3, Michael M. Ward4, Michael A. Fischer5 and Karen H. Costenbader6, 1Medicine, University of California, San Francisco, San Francisco, CA, 2Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Boston, MA, 4Bldg 10 CRC Rm 4-1339, NIAMS/NIH, Bethesda, MD, 5Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, 6Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: The contribution of uneven health care quality to racial/ethnic and socioeconomic disparities in lupus nephritis outcomes is unknown.  We aimed to assess performance on…
  • Abstract Number: 2601 • 2012 ACR/ARHP Annual Meeting

    Improving Delivery of Care for JIA Across a Multi-Center Network Using a Shared Data Registry and Quality Improvement Science: The Pediatric Rheumatology Care and Outcomes Improvement Network

    Catherine A. Bingham1, Lynn M. Darbie2, Keith Marsolo3, Jennifer E. Weiss4, Stacy P. Ardoin5, Ronald Laxer6, D. J. Lovell7, Murray H. Passo8, Sheetal Vora9, Beth S. Gottlieb10, Timothy Beukelman11, Nancy Griffin2, Jason A. Stock12, Michael L. Miller13, Karen Onel14, Tova Ronis15, Peter Margolis16 and Esi M. Morgan DeWitt17, 1Pediatric Rheumatology, Penn State Hershey Children's Hospital, Hershey, PA, 2James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Division of Biomedical Informatics, Cincinnati Children's Hospital, Cincinnati, OH, 4Pediatric Rheumatology, Hackensack University Medical Center, Hackensack, NJ, 5Pediatric & Adult Rheumatology, Ohio State University College of Medicine, Columbus, OH, 6Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 7Cincinnati Children's Hospital, Cincinnati, OH, 8Pediatric Rheumatology, Medical University of South Carolina, Charleston, SC, 9Pediatric Rheumatology, Medical College of Wisconsin, Milwaukee, WI, 10Pediatric Rheumatology, Cohen Children's Medical Center of New York, New Hyde Park, NY, 11Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 12Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 13Rheumatology, Childrens Memorial Hospital, Chicago, IL, 14Pediatric Rheumatology, University of Chicago, Chicago, IL, 15Pediatric Rheumatology, Stanford University Hospital, Palo Alto, CA, 16Clinical Effectiveness, Cincinnati Children's Hospital, Cincinnati, OH, 17Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: The Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) is a quality improvement (QI) multi-center “learning network” that performs QI and research while tracking…
  • Abstract Number: 2602 • 2012 ACR/ARHP Annual Meeting

    The Rheumatology Informatics System for Effectiveness (RISE): Enabling Data Access Across Disparate Sites for Quality Improvement and Research

    Peter J. Embi1, Itara Barnes2, Rachel Myslinski3, David Ervin4, William Stevens4, Tara Borlawsky1 and Philip R.O. Payne1, 1Biomedical Informatics & Internal Medicine, The Ohio State University, Columbus, OH, 2Quality, Registries, and Health Informatics, American College of Rheumatology, Atlanta, GA, 3Practice, Advocacy, & Quality, American College of Rheumatology, Atlanta, GA, 4The Ohio State University, Columbus, OH

    Background/Purpose: Rheumatology quality improvement efforts and clinical research are often challenged by the need to access and integrate data across diverse patient populations and disparate information…
  • Abstract Number: 2603 • 2012 ACR/ARHP Annual Meeting

    Moving Into the Electronic Age:  Validation of Rheumatology Self-Assessment Questionnaires On Tablet Computers

    Jessica M. Sage1, Arshia Ali2, Jennifer Farrell3, Jennifer L. Huggins4, Kara Covert3, Diane Eskra5, Rina Mina3, Shweta Srivastava3, Janalee Taylor6, Tracy V. Ting4, Esi M. Morgan DeWitt3 and Hermine Brunner4, 1Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Internal Medicine, University of Cincinnati, Cincinnati, OH, 3Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 6William S. Rowe Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: The medical field is increasingly relying on electronic health records (EHR). Many children’s hospitals are converting from paper-pencil questionnaires to electronic versions. The purpose…
  • « Previous Page
  • 1
  • …
  • 2429
  • 2430
  • 2431
  • 2432
  • 2433
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology